• Home
  • HCN Trends
  • Contact Us

Search Articles

Cardiology Covid-19 Dermatology Endocrinology General Interest Hematology Infectious Disease Neurology Oncology Pediatrics Psychiatry Pulmonology Rheumatology Surgery Uncategorized
acetaminophen actemra adverse events anemia antibody anxiety aspirin azithromycin bipolar disorder bleeding blog brain tumor breast cancer burnout Cancer capecitabine capmatinib cervical cancer chloroquine chronic pain clinical trials cll cloroquine CME compensation core-binding factor coronary artery disease coronavirus cost covid-19 cvd death diagnosis disease doctors dosing drug drug interactions efficacy erlotinib exercise FDA/regulation fever filters fish oil glioblastoma green tea guidelines hemophilia hiv hospital hydroxychloroquine ibrutinib ibuprofen immunity induction chemotherapy infectious disease influenza ipilimumab irinotecan iron-deficiency anemia isn letrozole leukemia Lung cancer malaria malpractice mask Masks mbc MDS medical cannabis medical school Medicine mesothelioma metastatic colorectal cancer methotrexate Myelodysplastic Syndromes myeloid leukemia nivolumab nsclc nursing oil olaparib osimertinib outcomes pandemic patient safety patients pd pediatrics perjeta physicians podcast practice practice management prevention primer procedure prostate cancer radiation recovery remdesivir research/studies respirators respiratory retevmo risk rucaparib sars SARS-CoV-2 infection SCLC selinexor selpercatinib side effects sorafenib stroke Survival/Mortality symptoms syndrome tazemetostat telemedicine testing therapeutics therapy thrombosis thyroid cancer time tnbc tocilizumab trastuzumab trauma treatment tweet vaccine venclexta venetoclax walking wound xpovio

Tag: Lung cancer

Wyanoke GroupUSPSTF: Start Lung Cancer Screening Earlier

In addition to reducing pack-years history of smoking, the recommendation calls for annual screening for lung cancer at age 50 years instead of age 55 years, an update of the U.S. Preventive Services Task Force (USPSTF) guidance on lung cancer screening issued 7 years ago.

Lung cancerCancerresearch/studies

Caribou PublishingASCO20 Plenary Sessions

On May 31, 2020, at the virtual scientific program of the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Sessions, late-breaking data dropped for three potentially practice-changing studies: JAVELIN Bladder 100, KEYNOTE-177, and ADAURA.

Lung cancerosimertinibtreatment

The New England Journal of MedicineAnetumab Ravtansine Shows Encouraging Activity in Multiple Solid Tumor Types

In this Journal of Clinical Oncology study, anetumab ravtansine yielded manageable safety, tolerability, pharmacokinetics, and clinical activity in a study of 148 heavily pretreated patients with mesothelin-expressing solid tumors.

treatmentLung cancerosimertinib
  • © Healthcare Communications Network
  • Privacy Policy